NEW YORK (GenomeWeb News) – Next-generation sequencing-based carrier screening firm Good Start Genetics today announced it has closed a non-dilutive loan facility for up to $28 million from Capital Royalty.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.